Starting Smoking Cessation in Hospitalized Patients Would Reduce Many Premature Deaths

Each year in the U.S., about 30 million hospitalizations occur in individuals 18 and older. Of these, more than 7 million are current cigarette smokers whose average hospital stay is several days. Researchers say that starting smoking cessation therapy during hospitalization and maintaining high adherence post-discharge can markedly improve permanent quit rates in these patients with minimal to no side effects. Cessation therapy also should include long-term counseling and at least 90 days of a prescription drug, specifically, varenicline.

Read more

Quit the Hookah! Lung Damage, Inflammation Is Reversible with Smoking Cessation

New research finds that quitting smoking is an effective way to resolve impaired lung function and airway inflammation associated with waterpipe smoking. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology.

Read more

Emotional dependency on smoking-vaping combo differs from just smoking

Researchers have known that emotions play a critical, but complex role in shaping dependency on smoking and vaping. Now, a team of researchers report that emotions that trigger dependency for people who both smoke and vape may be different from people who just smoke, a finding that may one day help scientists create more personalized programs to help people quit tobacco smoking and vaping.

Read more

Protect Your Bladder: Quit Smoking

Your bladder probably isn’t your favorite topic of conversation, but knowing when to talk to your doctor about it is crucial to your health. If you experience frequent and/or painful urination, or you notice blood in your urine, telling your primary care provider is the first step to diagnosing a problem and finding the right care. More often than not, these symptoms are caused by non-life-threatening conditions like urinary tract infection, overactive bladder or, in men, an enlarged prostate. But they also could be symptoms of bladder cancer, the sixth most common form of cancer in the United States.

Read more

Experts Strongly Recommend Varenicline Over the Patch for Adult Smokers Hoping to Quit

Smoking cessation initiatives notwithstanding, along with provocative public health campaigns and clinical guidance, quitting tobacco has remained elusive for many smokers. The American Thoracic Society’s new clinical practice guideline on treatment for tobacco dependence in adults addresses how clinicians may deal with patients’ reluctance to quit, one of a number of issues not previously assessed in the older guidelines.

Read more

Continued nicotine use promotes brain tumors in lung cancer patients, Wake Forest study suggests

Researchers at Wake Forest School of Medicine have discovered that nicotine promotes the spread of lung cancer cells into the brain, where they can form deadly metastatic tumors. The study, which will be published June 4 in the Journal of Experimental Medicine (JEM), suggests that nicotine replacement therapies may not be suitable strategies for lung cancer patients attempting to quit smoking. In addition, the researchers show that the naturally occurring drug parthenolide blocks nicotine-induced brain metastasis in mice, suggesting a potential therapeutic option in humans.

Read more

UniSA research uncovers treatment combo that sees smokers six times more likely to stop smoking and stay smoke-free

New research led by the University of South Australia has found that smokers who receive the medication varenicline tartrate combined with Quitline counselling following a period of hospitalisation due to a tobacco-related illness are six times more likely to quit smoking than those who attempt to stop without support.

Read more

Case Western Reserve researchers to lead Northeast Ohio initiative to prevent, detect and treat lung cancer in underserved communities

With a $2.75 million, three-year grant from the Bristol-Myers Squibb (BMS) Foundation, researchers from Case Western Reserve University will lead a community wide initiative to create and apply innovative methods to prevent and detect lung cancer in underserved residents in Northeast Ohio.

Read more